
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you open and fund a new account within 30 days
- Access to a financial planner
Walgreens Boots Alliance is a pharmaceutical retailers business based in the US. Walgreens Boots Alliance shares (WBA) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $11.17 – an increase of 0.45% over the previous week. Walgreens Boots Alliance employs 193,000 staff and has a trailing 12-month revenue of around $150.4 billion.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Latest market close | $11.17 |
---|---|
52-week range | $7.98 - $20.32 |
50-day moving average | $10.89 |
200-day moving average | $10.45 |
Wall St. target price | $12.29 |
PE ratio | N/A |
Dividend yield | $1 (8.94%) |
Earnings per share (TTM) | $-10.24 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $11.19 from 2025-03-28
1 week (2025-03-25) | 0.63% |
---|---|
1 month (2025-02-28) | 4.78% |
3 months (2024-12-31) | 19.94% |
6 months (2024-10-01) | 28.62% |
1 year (2024-04-01) | -42.73% |
---|---|
2 years (2023-03-31) | -62.95% |
3 years (2022-04-01) | 36.4708 |
5 years (2020-04-01) | 32.9564 |
Valuing Walgreens Boots Alliance stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Walgreens Boots Alliance's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Walgreens Boots Alliance's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.5531. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Walgreens Boots Alliance's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Walgreens Boots Alliance's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.8 billion.
The EBITDA is a measure of a Walgreens Boots Alliance's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | $150.4 billion |
---|---|
Gross profit TTM | $26.5 billion |
Return on assets TTM | 0.55% |
Return on equity TTM | -80.85% |
Profit margin | -5.87% |
Book value | $11.51 |
Market Capitalization | $9.7 billion |
TTM: trailing 12 months
Dividend payout ratio: 49.02% of net profits
Recently Walgreens Boots Alliance has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Walgreens Boots Alliance shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Walgreens Boots Alliance's case, that would currently equate to about $1 per share.
While Walgreens Boots Alliance's payout ratio might seem fairly standard, it's worth remembering that Walgreens Boots Alliance may be investing much of the rest of its net profits in future growth.
Walgreens Boots Alliance's most recent dividend payout was on 11 December 2024. The latest dividend was paid out to all shareholders who bought their shares by 17 November 2024 (the "ex-dividend date").
Walgreens Boots Alliance's shares were split on a 2:1 basis on 15 February 1999 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Walgreens Boots Alliance shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Walgreens Boots Alliance shares which in turn could have impacted Walgreens Boots Alliance's share price.
Over the last 12 months, Walgreens Boots Alliance's shares have ranged in value from as little as $7.9777 up to $20.3241. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Walgreens Boots Alliance's is 0.598. This would suggest that Walgreens Boots Alliance's shares are less volatile than average (for this exchange).
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally. It operates through three segments: U. S. Retail Pharmacy, International, and U. S. Healthcare.
Steps to owning and managing MRK, with 24-hour and historical pricing before you buy.
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
Steps to owning and managing ISRG, with 24-hour and historical pricing before you buy.
Steps to owning and managing VRTX, with 24-hour and historical pricing before you buy.
Steps to owning and managing MCK, with 24-hour and historical pricing before you buy.
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
Steps to owning and managing AMGN, with 24-hour and historical pricing before you buy.
Steps to owning and managing ABT, with 24-hour and historical pricing before you buy.
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.